Cited by 285Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy researchRNA Interference and Gene Delivery

Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy

Valori, Chiara F., Ning, Ke, Wyles, Matthew, Mead, Richard J., Grierson, Andrew J., Shaw, Pamela J., Azzouz, Mimoun·2010·Science Translational Medicine

Abstract

An adeno-associated virus vector expressing the survival motor neuron protein rescues mice with spinal muscular atrophy.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3000830

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ability of the recombinant AAV genome to persist as an episome in post-mitotic cells, such as neurons, ensures long-term expression even after a single administration.

    “Especially considering the ability of the recombinant AAV genome to persist as an episome in post-mitotic cells, such as neurons, which ensures long-term expression even after a single administration [130-132].”

The citation lists haven’t been fetched yet

References 29 · Cited by 285

Authors
Valori, C. F., Ning, K., Wyles, M., Mead, R. J., Grierson, A. J., Shaw, P. J., & Azzouz, M.
Affiliations
University of Sheffield (GB)
Corresponding author
  • Valori, Chiara F.
  • Ning, Ke
  • Azzouz, Mimoun
Venue
Science Translational Medicine
Published
2010-06-09
Volume
2
Issue
35
Pages
35ra42-35ra42
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2147552101
Cited by
285
References
29
Citations by year
2026: 5 · 2025: 1 · 2024: 19 · 2023: 13 · 2022: 11 · 2021: 15 · 2020: 18 · 2019: 20 · 2018: 11 · 2017: 23 · 2016: 18 · 2015: 25 · 2014: 26 · 2013: 26 · 2012: 15
FWCI
11.43
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
spinal muscular atrophy, SMN1, gene therapy, systemic gene delivery, survival motor neuron protein, transgenic mouse model, lifespan extension, motor neurons
MeSH terms
Dependovirus, Animals, Animals, Newborn, Base Sequence, Codon, Disease Models, Animal, Fibroblasts, Molecular Sequence Data, Motor Activity, Muscular Atrophy, Spinal, Mutation, Phenotype, Genetic Therapy, Survival Analysis, Gene Transfer Techniques, Mice, Survival of Motor Neuron 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review